January 03, 2024
BWXT Names Nicole W. Piasecki to Board of Directors
December 15, 2023
BWX Technologies to Host Investor Day on February 28, 2024
November 16, 2023
BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology
November 08, 2023
BWXT Selected as Nuclear Fuel and Component Manufacturer for Air Force Research Laboratory’s JETSON Program
November 01, 2023
BWX Technologies Reports Third Quarter 2023 Results
October 24, 2023
BWXT Announces $300 Million Contract for Naval Nuclear Reactor Fuel
October 02, 2023
BWX Technologies to Announce Third Quarter 2023 Results on Wednesday, November 1
September 20, 2023
BWXT, Crowley Debut Nuclear Power Generation Vessel Concept
September 20, 2023
Crowley, BWXT Debut Nuclear Power Generation Vessel Concept
September 12, 2023
BWXT Awarded Contract to Evaluate Microreactor Deployment for State of Wyoming
August 30, 2023
BWXT to Manufacture HALEU Feedstock for Advanced Reactors
August 03, 2023
BWX Technologies Reports Second Quarter 2023 Results
August 02, 2023
BWXT Awarded an Engineering Contract from TerraPower for the Natrium™ Demonstration Project
July 26, 2023
BWXT to Provide Nuclear Reactor Engine and Fuel for DARPA Space Project
June 27, 2023
BWX Technologies to Announce Second Quarter 2023 Results on Thursday, August 3
May 08, 2023
BWX Technologies Reports First Quarter 2023 Results
April 17, 2023
BWXT-led Team Awarded $45 Billion Environmental Management Contract for DOE’s Hanford Site
April 10, 2023
BWXT Subsidiary Awarded $428 Million Contract for Uranium Conversion and Purification Services
April 05, 2023
BWX Technologies to Announce First Quarter 2023 Results on Monday, May 8
March 21, 2023
BWXT Awarded Engineering Contract from GE Hitachi for BWRX-300 Small Modular Reactor
March 02, 2023
BWXT Releases 2023 Sustainability Report
February 23, 2023
BWX Technologies Reports Fourth-Quarter and Full-Year 2022 Results, Initiates 2023 Guidance and Increases Quarterly Cash Dividend
February 01, 2023
BWXT Medical and Laurentis Complete Key Tc-99m Generator Program Milestone
January 26, 2023
BWX Technologies to Announce Fourth Quarter and Full-Year 2022 Results on Thursday, February 23
January 05, 2023
Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
January 04, 2023
BWXT Promotes Chip Whitford to Senior Vice President and General Counsel
December 07, 2022
BWXT Starts Production of TRISO Fuel for First U.S. Generation IV Microreactor
November 07, 2022
BWX Technologies Reports Third Quarter 2022 Results
November 02, 2022
BWXT to Participate in Upcoming Investor Conferences
October 12, 2022
BWXT Closes Amended and Restated Credit Agreement
October 12, 2022
BWX Technologies to Announce Third Quarter 2022 Results on Monday, November 7
September 13, 2022
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
August 22, 2022
BWXT Names Robert Duffy as Chief Administrative Officer
August 08, 2022
BWX Technologies Reports Robust Second Quarter 2022 Results; Increases 2022 Revenue and Adjusted EBITDA(1) Guidance
July 27, 2022
BWXT Names Sharon H. Smoot as President of Nuclear Operations Group
July 14, 2022
BWX Technologies to Announce Second Quarter 2022 Results on Monday, August 8
July 05, 2022
BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power
June 27, 2022
BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
June 13, 2022
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
June 09, 2022
BWXT to Build First Advanced Microreactor in United States
May 09, 2022
BWX Technologies Reports First Quarter 2022 Results
May 03, 2022
BWXT Appoints Jan A. Bertsch as New Chair of Board of Directors
March 30, 2022
BWX Technologies to Announce First Quarter 2022 Results on Monday, May 9 and Issues Interim Update on Key Initiatives
February 28, 2022
BWXT Releases 2022 Sustainability Report
February 23, 2022
BWXT Awarded $1 Billion in Naval Nuclear Propulsion Program Options
February 22, 2022
BWXT Announces McCoy, MacQuarrie to Lead Newly Organized Reporting Segments
February 22, 2022
BWX Technologies Reports Fourth Quarter and Full-Year 2021 Results
January 31, 2022
BWX Technologies to Announce Fourth Quarter and Full-Year 2021 Results on Tuesday, February 22
November 15, 2021
BWXT Hosting Investor Day on Nov. 16
November 05, 2021
BWXT Names Robb A. LeMasters as Next Chief Financial Officer
Register for free today and gain instant access to over 15,000 stock hubs.